Cargando…
Overview of pharmacotherapy targeting COVID-19 disease based on ACE-2: current challenges and future directions
The new Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) triggered the pandemic of COVID-19, which is currently still ongoing. In 2021 a worldwide vaccine campaign was launched, and in parallel the lines of research are continuing to target the most effective drug therapies for the treat...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638345/ https://www.ncbi.nlm.nih.gov/pubmed/36331568 http://dx.doi.org/10.1007/s00059-022-05142-6 |